Update on coxsackievirus B3 myocarditis
- 1 July 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 24 (4) , 401-407
Abstract
Purpose of review To present recent findings on the pathogenesis of coxsackievirus B3 (CVB3) myocarditis based on animal models, with a focus on the role of T helper (Th) immune responses in disease progression. Recent findings Acute CVB3 myocarditis is known to be increased by Th1 immune responses, but recent findings indicate that Th1-type immunity protects against acute myocarditis by reducing viral replication and prevents the progression to chronic myocarditis and dilated cardiomyopathy (DCM) by inhibiting Th2 responses. Th2 responses reduce acute myocarditis by inhibiting Th1 responses via regulatory T cells and anti-inflammatory cytokines, but can be deleterious when they induce acute cardiac remodeling leading to chronic myocarditis/DCM. Th2-skewed immune responses allow resistant strains of mice to progress from myocarditis to DCM. In contrast, Th17 responses are elevated during acute and chronic myocarditis and have been found to contribute to cardiac remodeling and DCM. Summary Recent data indicate that elevated Th2 and Th17 responses during acute CVB3 myocarditis are critical for the progression from myocarditis to DCM and heart failure because of their ability to induce cardiac remodeling. Th1 responses protect against CVB3 myocarditis by inhibiting Th2 responses and viral replication, but increase acute inflammation.Keywords
This publication has 61 references indexed in Scilit:
- Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3nAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Histamine H1 receptor signaling regulates effector T cell responses and susceptibility to coxsackievirus B3-induced myocarditisCellular Immunology, 2012
- Th2 Regulation of Viral Myocarditis in Mice: Different Roles for TLR3 versus TRIF in Progression to Chronic DiseaseJournal of Immunology Research, 2011
- Low-Dose Inorganic Mercury Increases Severity and Frequency of Chronic Coxsackievirus-Induced Autoimmune Myocarditis in MiceToxicological Sciences, 2011
- Critical Cytokine Pathways to Cardiac InflammationJournal of Interferon & Cytokine Research, 2011
- Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditisJournal of Autoimmunity, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammationVirology Journal, 2011
- Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditisEuropean Heart Journal, 2010
- Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicityMethods, 2007